Test Script

National Pharmaceutical Pricing Authority (NPPA) was constituted through a Government of India Resolution dated 29th August, 1997 as an attached office of the Department of Pharmaceuticals (DoP), Ministry of Chemicals & Fertilizers as independent regulator for pricing of drugs and to ensure availability and accessibility of medicines at affordable prices. NPPA's key responsibilities include fixing and revising drug prices as per the provisions of the Drugs Prices Control Order (DPCO), monitoring compliance and availability of drugs, and rendering advise on pharmaceutical policies. Currently, NPPA is implementing the Drugs (Price Control) Order, 2013 issued by the Department of Pharmaceuticals (DoP) as per the powers delegated to it.NPPA provides ceiling price to all drugs notified under Schedule-I of DPCO and so far, it has given ceiling price to 928 scheduled formulations and retail Price to around 3111 new drugs. By invoking powers under Para 19 of DPCO, 2013, it has regulated prices of 106 anti-diabetic and cardio vascular drugs; coronary stents and knee implants in public interest. In February, 2019, NPPA regulated the prices of 42 anti-cancer non-scheduled drugs under Trade Margin rationalization resulting in savings up to 90% amounting in case of 526 brands. During COVID pandemic too, NPPA had capped the trade margin of Oxygen Concentrators and five other medi...